Evidence map›Paper›PMID 30683927›Full record

Trial reportEuropean journal of human genetics : EJHG2019

Patient views on research use of clinical data without consent: Legal, but also acceptable?

Gesine Richter, Christoph Borzikowsky, Wolfgang Lieb, Stefan Schreiber, Michael Krawczak, Alena Buyx

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in European journal of human genetics : EJHG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Broad Consent in Healthcare Research: What Is Efficient, What Is Right?Journal of magnetic resonance imaging : JMRI · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The human genetic epidemiology of COVID-19.Nature reviews. Genetics · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Associations between the Willingness to Donate Samples to Biobanks and Selected Psychological Variables.International journal of environmental research and public health · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gesine RichterInstitute of Epidemiology, Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany. gesine.richter@iem.uni-kiel.de.
Christoph BorzikowskyInstitute of Medical Informatics und Statistics, Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany.
Wolfgang LiebInstitute of Epidemiology, Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany.
Stefan SchreiberDepartment of General Internal Medicine, University Hospital Schleswig-Holstein, Kiel, Germany.
Michael KrawczakInstitute of Medical Informatics und Statistics, Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany.
Alena BuyxInstitute of History and Ethics in Medicine, Technical University of Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The research exemption implemented in the new EU General Data Protection Regulation (EU-GDPR) gives member states leeway in determining whether patient consent is required for secondary data use in medical research. However, even though broad consent has become common in data-rich medical research in many EU countries, giving up consent altogether is likely to be controversial. The aim of this study was to examine whether abolishing consent for secondary data use would be acceptable to patients. A questionnaire study was conducted among 700 outpatients of a northern German university hospital to assess their attitude towards use of clinical data for scientific research without consent. There was both strong willingness to give broad consent for secondary data use (468 of 503 responders, 93.0%) and strong approval of abolishing patient consent (n = 381, 75.7%) among study participants. The willingness to give consent was moderately associated with approval of the respective stipulations by the EU-GDPR. In research settings where broad consent is widely accepted (e.g. university hospitals), abolishing consent for secondary research use of clinical data will likely be acceptable to a large majority of patients.

Indexed as

AttitudeSurveys and QuestionnairesAdultBiomedical ResearchEuropean UnionFemaleHumansInformed ConsentMale

Identifiers

PMID30683927
PMCPMC6777530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.